Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2008 Apr 11.
Published in final edited form as: Dement Geriatr Cogn Disord. 2008 Feb 13;25(3):266–271. doi: 10.1159/000115976

Memory Decline and Depressive Symptoms in a Nationally Representative Sample of Older Adults: The Health and Retirement Study (1998–2004)

Hector M González 1,2,3, Mary E Bowen 1, Gwenith G Fisher 3
PMCID: PMC2292399  NIHMSID: NIHMS41453  PMID: 18270489

Abstract

Background

Inconsistencies in the relationship between depression and cognitive decline may exist because the expected cognitive domains at-risk have not been specified in previous study designs.

Objectives

To examine the relationship between depressive symptoms and verbal episodic memory functioning over time.

Design

Prospective cohort study (Health and Retirement Study HRS; 1998–2004), a multistage probability sample of adults 51 years and over in 1998, was analyzed.

Setting

Contiguous 48 United States

Participants

Nationally representative sample of older adults (51+ years) in 1998 (N=18,465)

Main Outcomes

Verbal learning and memory of a ten-word list learning task.

Main Predictor

Depressive symptoms (Center for Epidemiologic Studies—Depression Scale; (CES-D)

Results

Depressive symptoms were associated with significantly lower Immediate (−0.05; p<0.001) and Delayed (−0.06; p<0.001) word list recall scores after controlling for demographics and baseline and time-varying cardiovascular disease risks and diseases.

Conclusions

In this U.S. national study of older adults, elevated depressive symptoms were associated with declines in episodic learning and memory over time. These associations were little affected by demographic or medical conditions considered in this study. The results suggest that learning and memory decline may be a long-term feature associated with depressive symptoms among the nation’s older adult population.

Keywords: depression, cognitive decline, older adults, learning, memory

INTRODUCTION

Depression is a leading cause of disability in the U.S. and worldwide.[1] One means by which depression may affect disability is through cognitive dysfunction, which is a symptom of depression.[2] In cross-sectional studies, depression is associated with lower cognitive functioning, particularly episodic memory (also known as declarative memory).[36] In addition, medial temporal lobe brain regions that are associated with episodic memory have been reported to be reduced in people with depression although not consistently.[7] Further, some reports have indicated improvements in hippocampal activity and cognitive functioning following antidepressant treatment;[8] but not in a randomized trial.[9] Depression-related cortisol dysregulation has been suggested as a possible mechanism for the negative changes in brain activity and structure, and episodic learning and memory.[10, 11]

Several reports from longitudinal studies of the effects of depression have focused on global cognitive functioning (e.g., mental status exams), neuropsychological test composite scores, or the prediction of dementia, and have yielded inconsistent findings.[1214] In light of work suggesting that depression may selectively affect brain regions associated with verbal episodic learning and memory,[15, 16] the purpose of this study was to examine the longitudinal association between depressive symptoms and episodic learning and memory in a nationally representative sample of older adults. It was expected that more depressive symptoms over the six-year study would be associated with lower learning and memory performance.

METHODS

Data

The Health and Retirement Survey (HRS) is a prospective cohort study that is conducted by the University of Michigan with support from the National Institute of Aging. The first wave of the HRS occurred in 1992 with a 51 to 61 year-old cohort and was merged with the older (70 years and older) Asset and Health Dynamics of the Oldest Old Study (AHEAD) cohort in 1998. Two additional cohorts were added in 1998 to fill in the gaps between these two groups, resulting in a sample design nationally representative of the U.S. population over age 50 in 1998. Briefly, the HRS is a multistage probability cohort sample of U.S. households. Further details on the HRS design and methods have been previously published (see Heeringa & Connor, 1996).[17]

We analyzed four waves of data (1998 to 2004) from the HRS that was prepared by the RAND Center for the Study of Aging (RAND HRS) for this study. The benefits of using the RAND HRS data include consistent depression and disease reports over the survey period, model-based imputations of missing data, and comparability of variables across survey waves (see RAND HRS, 2006, for details).[18] We analyzed data from 18,465 community-dwelling respondents who were 51 years or older in 1998. The HRS sample demographic characteristics are presented in Table 1. Respondents with sampling weights of zero indicating they were institutionalized or deceased were excluded from this study. Data were weighted using HRS respondent-level sampling weights to account for the sample design in the HRS (Heeringa & Connor, 1995). After four waves (1998 – 2004), the combined year response rate was 72.3%. The wave-to-wave re-interview response rates ranged from 92.1% (2000) to 87.5% (2004).

Table 1.

Baseline Year Characteristics (Unweighted N and Weighted Percentages) of Community-dwelling Older Adults (51 years and over) in the Health and Retirement Study (1998–2004; n=18,465).

Variables N %
Age Groups (Years)
 51–59 5,185 37.0
 60–69 6,342 28.4
 70–79 4,504 23.6
 80+ 2,434 11.0
Sex
 Male 7,598 42.8
 Female 10,867 57.2
Race
 White 15,334 87.7
 Nonwhite 3,119 12.3
Education Group (Years)
 0–11 4,319 23.2
 12 6,278 36.3
 12+ 6,869 40.5
*

Respondent baseline characteristic totals differ due to missing data on some measures

Score ranges from 0–8.

Note: M is mean and SD is standard deviation.

Measures

The main variables of interest in this study were administered at every wave (i.e., every two years) of the HRS (1998–2004) and were time-varying. The outcome variables of interest in this study were the immediate and delayed memory scores of a ten-word list-learning task administered to all capable HRS respondents. In telephone and face-to-face interviews, three alternative lists of ten common nouns were read to respondents at a rate of one per second. Immediately after the word list was read, respondents were asked to repeat as many words as they could recall in any order (immediate). After about three minutes of interference tasks, respondents were asked to recall the ten-word list again (delayed). The scores ranged from 0 to 10 words recalled for the immediate and delayed trials. The interview modes (i.e., telephone and face-to-face) and the use of four alternative list forms have been found to have minimal effects on performance; however, learning effects from previous test exposures were reported.[19]

The main predictor variable of interest was depression, measured by a Center for Epidemiologic Studies—Depression Scale (CES-D).[20] The CES-D is a self-reported inventory of depressive symptoms (“was depressed,” “everything was an effort,” “sleep was restless,” “was happy,” “felt lonely,” “enjoyed life,” “felt sad,” and “could not get going”) that occurred in the week prior to the respondents’ interview date. The HRS uses an eight-item version of the full twenty-item CES-D which were selected based on factor analyses.[21] The eight-item CES-D version reportedly has similar symptom dimensions as the original CES-D and high internal consistency and validity in the HRS.[22, 23] In this study, the baseline internal consistency reliability coefficient (alpha) of the CES-D scale was 0.77. The dichotomously scored CES-D items ranged from 0–8 with 8 indicating the most depressive symptoms in this study. Most of the respondents in this community-dwelling sample reported few depressive symptoms overall (baseline mode = 0, mean = 1.62; see Wallace, et al., 2000).[23] Additionally, demographic variables (non-time-varying) and time-varying self-reported risk factors for vascular disease or vascular disease were included as covariates. The demographic measures included: sex (male=0, female=1), race (white=0, nonwhite=1), education (0 to 17 or more years), and age in years. Age was centered at 65 years for ease of interpretation and to restrict problems with collinearity.[24, 25] Time-varying diabetes, hypertension, stroke, and cardiovascular disease (CVD) were coded dichotomously as present or absent. Diabetes and hypertension were aggregated to indicate CVD risk; stroke and CVD were aggregated to indicate CVD. At baseline, respondents were asked if a doctor had ever told them that they had these conditions (i.e., measure of prevalent conditions). In later survey waves, respondents were asked if they had been told by a doctor (since the prior interview) that they had developed any of these conditions (i.e., measure of incident conditions). Reasonable concordance values between self-reports of disease and medical chart reviews have been reported.

Analytic Approach

Multilevel statistical modeling using Hierarchical Linear Modeling software version 6.02 (HLM; Scientific Software International, Lincolnwood, IL) was used to examine individual and aggregate levels of data over time.[24] Basically, multilevel modeling in HLM conceives of each individual as having their own regression equation. We present our hierarchical models as a series of nested models, one for each level of the hierarchy. At the first level, each individual respondent’s trajectory of change in learning and memory was represented as a function of person-specific parameters (e.g., risk for CVD, CVD, CES-D), plus random error. The second level statistically modeled individual variations in growth parameters across a population of persons (e.g., sex, race, education, and the number of previous word list exposures). The third level additionally adjusted our analyses for same household respondents, as cohabitating individuals in the same household may be more similar to one another than households with only one respondent. The multilevel assumption of normality was examined and revealed no violation of this assumption.

Two separate pairs of multilevel models were used to examine immediate and delayed word list scores. In both models, the count of depressive symptoms endorsed was the main predictor, with covariates for sex, race, education, wordlist exposure frequency, and households with more than one respondent (see below).

RESULTS

Bivariate Results

Table 1 shows the baseline characteristics of the sample. As shown in Table 1, the sample was largely white and female. Most respondents were between the ages of 60–69 (mean = 66.9) at the 1998 baseline year and a most respondents had 12 years of education or more. Table 2 shows the weighted means and standard deviations of the immediate and delayed word list scores by interview regardless of wave. As Table 2 shows, the respondent’s average immediate and delayed word list scores decreased from their first interview to their third interview, and increased in their fourth interview. The immediate and delayed recall score increases in the fourth interview may have been associated with learning effects.

Table 2.

Weighted Learning (Immediate) and Memory (Delayed) Score Averages from a Ten Word List Learning Task by Respondent Interview* The Health and Retirement Study (1998–2004; n=18,465).

Immediate Word List Recall Delayed Word List Recall
M SD M SD N
Respondent Interview
1st 5.74 1.82 4.68 2.18 18,465
2nd 5.30 1.84 4.17 2.11 17,015
3rd 5.16 1.81 4.12 2.12 15,268
4th 5.44 1.68 4.39 2.03 13,358
*

Scores are calculated based on the respondent’s interview regardless of the wave year. For example, interview 1 indicates the first interview the respondent had, which could be on or after wave year 1998

The incidence of acute and chronic conditions increased with each survey wave (not shown). At baseline, about 20% of respondents reported ever having risks for CVD while 21% of respondents reported ever having CVD. In 2004, the six-year incidence of new self-reported cases of CVD risks was 1.5% and 8% for CVD.

Multivariate Results

Immediate Word List Results

Table 3 (model 1) shows the relationship between CES-D and immediate word list recall scores after adjustment for demographic variables.

Table 3.

Estimated Associations between Learning and Memory (Immediate and Delayed Word List Recall Scores) and Depressive Symptoms (Center for Epidemiologic Studies-Depression Scale) in U.S. Community-dwelling Adults (ages 51 years and over) from the Health and Retirement Study (1998–2004)

Immediate Word List Delayed Word List
Model 1 Model 2 Model 1 Model 2
Coefficients SE Coefficients SE Coefficients SE Coefficients SE
Mean Wordlist Score 3.05* 0.04 3.16* 0.05 1.69* 0.05 1.83* 0.06
Mean Wordlist Growth Rate −0.07* 0.00 −0.07* 0.00 −0.08* 0.00 −0.08* 0.00
Depressive Symptoms −0.06* 0.00 −0.05* 0.00 −0.07* 0.00 −0.06* 0.00
Cardiovascular Disease Risk Factors −0.07* 0.01 −0.10* 0.01
Cardiovascular Disease Events −0.14* 0.02 −0.16* 0.01
Model Fit
Deviance Estimated 215,817.28 215,528.47 234,944.55 234,687.73
Parameters 10 12 10 12
Model Comparisons Model 1 vs. Model 2 Δx 2=288.81
df=2; p<0.001
Model 3 vs. Model 4 Δx 2=246.82
df=2; p<0.001
a

Based on responses to a 10 word immediate and delayed recall wordlist.

Note: CVD is cardiovascular disease

Models are adjusted for immediate and delayed word list exposure frequency and married/partnered couples.

*

p<0.001

In the model 1, CES-D was negatively associated with immediate word list scores (−0.06; p<0.001). That is, with each depressive symptom, respondents recalled 0.06 fewer words. Model 2 was additionally adjusted for baseline and time-varying CVD risk factors and CVD. The variables added to Model 2, did not significantly affect the association between CES-D and immediate word list recall scores. That is, with each depressive symptom, respondents continued to recall fewer words (−0.05; p<0.001). Risks for CVD (p<0.001) and CVD (p<0.001) were associated with fewer words recalled, and the average respondent with CVD recalled fewer words (−0.14; p<0.001) than the average respondent with CVD risks (−0.07; p<0.001). A hypothesis test was used to compare immediate models 1 and 2 by examining the significance of the change in −2 log likelihood chi-square between the models, the results of which are shown at the bottom of Table 3. Though adjustments for CVD risk and CVD did not better explain the relationship between CES-D and immediate word list scores, the model fit statistics show that these adjustments in the immediate model 2 did improve the model fit to the data, with a significant (p<0.001) change in the −2 log likelihood chi-square (288.81; df = 2).

Delayed Word List Recall Results

Table 3 shows the relationship between CES-D and delayed word list recall scores after demographic adjustments. In the model 1, CES-D was negatively associated with delayed word list recall (−0.07; p<0.001). That is, with each depressive symptom, there were 0.07 fewer words recalled in the delayed word list trial. The relationship between delayed word list recall scores and CES-D remained largely unchanged after controlling for CVD risk factors and CVD in the delayed model 2 (−0.06; p<0.001). That is, in the delayed model 2, with each additional depressive symptom, word recall decreased by 0.06 (p<0.001). CVD risk and CVD were associated with fewer words recalled.

The average respondent with CVD conditions recalled fewer words (−0.16; p<0.001) than the average respondent who was just at-risk for CVD (−0.10; p<0.001). A hypothesis test was used to examine the significance of the change in −2 log likelihood chi-square between the delayed word list recall models 1 and 2, the results of which are shown at the bottom of Table 2. Though CVD risk and CVD did not better explain the relationship between delayed word recall and CES-D, model fit statistics show that these adjustments in the delayed model 2 did improve model fit to the data, with a significant (p<0.001) change in the −2 log likelihood chi-square (246.82; df = 2). In sum, as CES-D increased, the number of words recalled in both the immediate and delayed word recall trials decreased. The relationship between CES-D and immediate and delayed word list recall was not better explained by demographics or baseline and time-varying adjustments for CVD risks factors and CVD.

Conclusion

Over the course of six years, elevations in depressive symptoms were associated with lower verbal episodic learning and memory scores in this nationally representative sample of community-dwelling older adults. A major finding of this study was that by specifying a cognitive domain that is associated with chronic stress and the negative affects of depression in both non-human and human studies,[11, 26] we were able to demonstrate verbal episodic learning and memory decline over time. These findings suggest that depressive conditions that affect many older adults may be associated with dysfunction of brain regions associated with verbal episodic learning and memory. This is particularly important since memory loss is the vanguard of dementia in most patients.[2] The findings presented here support the hypothesis that chronic stress and depression are associated with failing hippocampal function.[10] Clinically, these findings support the regular practice of depression screening of patients with memory complaints.[14]

Previous longitudinal studies of depression have not consistently found cognitive decline. Most of these studies have not specified the cognitive domains that would be expected to be negatively affected by depression, which may explain inconsistencies in the findings of earlier work. For example, several studies have relied on global cognitive function measures, such as the Mini Mental State exam, or neuropsychological batteries reduced to composite scores for identifying cognitive impairment or dementia.[1214, 27] Findings from the longitudinal studies that provided verbal episodic learning and memory performance information are mixed, which may be related to attrition, the limited availability of follow-up waves of information, and the methods used for longitudinal data analyses.[14, 28]

The results presented here are consistent with cross-sectional findings of associations between depressive symptoms and lower verbal episodic learning and memory performance.[3, 15] In these cross-sectional and many of the longitudinal studies above, the neurotoxic affects of cortisol dysregulation on hippocampal function was considered as a possible explanation for the lower verbal episodic learning and memory performance and hippocampal atrophy on MRI for depressed participants.[15, 16] The verbal episodic learning and memory decline results presented here are supportive of the hypothesis that depressive symptom related allostatic load negatively affected hippocampal functioning in this sample.

A major strength of this study is that it used multi-level statistical analyses that considered within and between person estimates, and time-varying depression, medical conditions and other non-varying covariates. Multi-level analyses accounts for autocorrelation problems associated with repeated measures analyses that may have affected analyses in previous reports. Few of the previous reports examining the association between depression and cognitive change have accounted for these important factors in their analytic approaches. Those studies that have analyzed their data using similar approaches to this study have found associations between depressive symptoms and cognitive decline.[13, 14] To the best of our knowledge, the results presented here from HRS represent the largest study of the association between depression and cognitive decline. Because our results represent national estimates, they can be generalized to the entire population of non-institutionalized, community-dwelling older adults in the U.S.

The results of this study indicate that depressive symptoms are associated with verbal episodic learning and memory decline. The significant declines were not explained by other important medical comorbidities and demographic information. Indeed, medical conditions associated with vascular disease and vascular diseases themselves were independently associated with verbal learning and memory decline. Although the focus of this report was not on the medical conditions used in this study, the results presented here are consistent with previous work indicating associations between vascular disease and cognitive change.[29, 30] Nevertheless, it remains possible that other unaccounted variables may explain the verbal episodic learning and memory decline associated with depressive symptoms found in this sample, and there are several limitations to consider when interpreting the results of this study. Although we were able to capture time-varying depressive symptoms over the six-year period of this study, we were not able to determine the level of depressive symptoms respondents may have experienced outside of the time periods examined. Secondly, other attentional and motivational factors not examined in this study may have contributed to the negative association between depressive symptoms and episodic learning and memory that were reported herein. Additionally, the response rate over the study period was high (72.3%). Nevertheless, attrition remains an important concern. Over the six-year period of this study, the response rate of HRS respondents with elevated depressive symptoms (i.e., CES-D>=4) was lower (68.5%) than respondents with fewer symptoms. The bias introduced by selective, depression-related attrition was likely to have been small; however any selective, depression-related attrition would likely have resulted in underestimates of the association between depressive symptoms and cognitive decline.

The relationship between depressive symptoms and verbal episodic learning and memory over six years of this study was small, but the rate of decline is similar to that reported by Wilson et al. (2002).[14] The following is an example of how the results of this study might translate at the individual level: a 70-year old White woman with twelve-years of education, diabetes and an endorsement of all 8 depressive symptoms would recall an estimated four words (4.06) on the delayed memory trial at baseline. With CES-D scores of 8 consistent across years, her estimated scores would drop to about half of a point (3.47 words) words after six years and below 3 (2.87 words) words after twelve years (about the 10th percentile). This example of depressive symptoms related verbal episodic memory decline is small and the threshold point of concern from the individual or significant others are not certain. However, this example of memory loss approaches clinical significance and may pose functional problems for the individual and family. The average level of depressive symptoms in this community-dwelling population was small. In populations with higher levels of depressive symptoms (e.g., older Mexican Americans) or among patients with chronic clinical depression, the effect on episodic learning and memory may be higher.[31] For many older adults, depressive symptoms are accompanied with a vascular disease event, such as myocardial infarction, which would likely contribute to further memory loss and impairment. The association between depressive symptoms and cognitive decline supports the practice of depression screening for older Americans, particularly those with cognitive complaints.

Summary

Elevated depressive symptoms were associated with declines in verbal learning and memory performance in a U.S. nationally representative sample of older adults. The results suggest that learning and memory decline may be a long-term feature associated with depressive symptoms among the nation’s older adult population.

Acknowledgments

Dr. González receives funding from the National Institute of Mental Health (MH 67726). Dr. Bowen is supported by a post-doctoral training grant awarded to the Wayne State University, Institute of Gerontology by the Agency for Healthcare Research and Quality. The authors wish to express their gratitude to Dr. David Steffens for reviewing the manuscript and providing insightful comments.

Footnotes

Conflicts of Interest: None to report

References

  • 1.McKenna MT, Michaud CM, Murray CJ, Marks JS. Assessing the burden of disease in the United States using disability-adjusted life years. Am J Prev Med. 2005 Jun;28(5):415–23. doi: 10.1016/j.amepre.2005.02.009. [DOI] [PubMed] [Google Scholar]
  • 2.APA. Diagnostic and Statistical Manual of Mental Disorders. 4. Washington, DC: American Psychiatric Association; 2000. Text Revision. [Google Scholar]
  • 3.Airaksinen E, Larsson M, Lundberg I, Forsell Y. Cognitive functions in depressive disorders: evidence from a population-based study. Psychological Medicine. 2004 Jan;34(1):83–91. doi: 10.1017/s0033291703008559. [DOI] [PubMed] [Google Scholar]
  • 4.Ilsley JE, Moffoot AP, O’Carroll RE. An analysis of memory dysfunction in major depression. Journal of Affective Disorders. 1995 Oct 9;35(1–2):1–9. doi: 10.1016/0165-0327(95)00032-i. [DOI] [PubMed] [Google Scholar]
  • 5.Kindermann SS, Brown GG. Depression and memory in the elderly: a meta-analysis. Journal of Clinical & Experimental Neuropsychology. 1997;19(5):625–42. doi: 10.1080/01688639708403749. [DOI] [PubMed] [Google Scholar]
  • 6.King DA, Caine ED, editors. Neuropsychological assessment of neuropsychiatric disorders. 2. New York: Oxford University Press; 1996. [Google Scholar]
  • 7.von Gunten A, Fox NC, Cipolotti L, Ron MA. A volumetric study of hippocampus and amygdala in depressed patients with subjective memory problems. Journal of Neuropsychiatry & Clinical Neurosciences. 2000 Fall;12(4):493–8. doi: 10.1176/jnp.12.4.493. [DOI] [PubMed] [Google Scholar]
  • 8.Mayberg HS, Brannan SK, Tekell JL, Silva JA, Mahurin RK, McGinnis S, et al. Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biological Psychiatry. 2000 Oct 15;48(8):830–43. doi: 10.1016/s0006-3223(00)01036-2. [DOI] [PubMed] [Google Scholar]
  • 9.Nebes RD, Pollock BG, Houck PR, Butters MA, Mulsant BH, Zmuda MD, et al. Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, double-blind clinical trial with nortriptyline and paroxetine. Journal of Psychiatric Research. 2003 Mar–Apr;37(2):99–108. doi: 10.1016/s0022-3956(02)00085-7. [DOI] [PubMed] [Google Scholar]
  • 10.Lee BK, Glass TA, McAtee MJ, Wand GS, Bandeen-Roche K, Bolla KI, et al. Associations of Salivary Cortisol With Cognitive Function in the Baltimore Memory Study. Arch Gen Psychiatry. 2007 2007 July 1;64(7):810–8. doi: 10.1001/archpsyc.64.7.810. [DOI] [PubMed] [Google Scholar]
  • 11.Sapolsky RM. The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death. Biological Psychiatry. 2000 Oct 15;48(8):755–65. doi: 10.1016/s0006-3223(00)00971-9. [DOI] [PubMed] [Google Scholar]
  • 12.Cervilla JA, Prince M, Joels S, Mann A. Does depression predict cognitive outcome 9 to 12 years later? Evidence from a prospective study of elderly hypertensives. Psychological Medicine. 2000 Sep;30(5):1017–23. doi: 10.1017/s0033291799002779. [DOI] [PubMed] [Google Scholar]
  • 13.Chodosh J, Kado DM, Seeman TE, Karlamangla AS. Depressive Symptoms as a Predictor of Cognitive Decline: MacArthur Studies of Successful Aging. Am J Geriatr Psychiatry. 2007 Mar 12; doi: 10.1097/01.JGP.0b013e31802c0c63. [DOI] [PubMed] [Google Scholar]
  • 14.Wilson RS, Mendes De Leon CF, Bennett DA, Bienias JL, Evans DA. Depressive symptoms and cognitive decline in a community population of older persons. Journal of Neurology, Neurosurgery & Psychiatry. 2004 Jan;75(1):126–9. [PMC free article] [PubMed] [Google Scholar]
  • 15.Sheline YI, Sanghavi M, Mintun MA, Gado MH. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. Journal of Neuroscience. 1999;19(12):5034–43. doi: 10.1523/JNEUROSCI.19-12-05034.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Mintun MA, Sheline YI, Moerlein SM, Vlassenko AG, Huang Y, Snyder AZ. Decreased hippocampal 5-HT2A receptor binding in major depressive disorder: in vivo measurement with [18F]altanserin positron emission tomography. Biological Psychiatry. 2004 Feb 1;55(3):217–24. doi: 10.1016/j.biopsych.2003.08.015. [DOI] [PubMed] [Google Scholar]
  • 17.Heeringa SG, Connor J. Technical Description of the Health and Retirement Study Sample Design: HRS/AHEAD Documentation Report DR-002. 1995. [Google Scholar]
  • 18.RAND. The National Institute on Aging and the Social Security Administration. 2006. RAND HRS Data, Version F. [Google Scholar]
  • 19.Rodgers WL, Ofstedal MB, Herzog AR. Trends in scores on tests of cognitive ability in the elderly U.S. population, 1993–2000. J Gerontol B Psychol Sci Soc Sci. 2003 Nov;58(6):S338–46. doi: 10.1093/geronb/58.6.s338. [DOI] [PubMed] [Google Scholar]
  • 20.Radloff L. The CES-D Scale: A Self-Report Depression Scale for Research in the General Population. Applied Psychological Measurement. 1977;1(3):385–401. [Google Scholar]
  • 21.Radloff LS, Teri L. Use of the Center for Epidemiological Studies-Depression Scale with older adults. Clinical Gerontologist. 1986;5(1–2):119–36. [Google Scholar]
  • 22.Steffick DE. HRS Documentation Report DR-005. Survey Research Center at the Institute for Social Research; Ann Arbor, MI: 2000. Documentation of Affective Functioning Measures in the Health and Retirement Study. [Google Scholar]
  • 23.Wallace R, Herzog AR, Ofstedal MB, Steffick D, Fonda S, Langa K. Documentation of affective functioning measures in the health and retirement study. University of Michigan; Ann Arbor, MI: 2000. [Google Scholar]
  • 24.Raudenbush S, Bryk AS. Hierarchical linear models: Applications and data analysis methods. Thousand Oaks, CA: Sage Publications, Inc; 2002. [Google Scholar]
  • 25.West BT, Welch KB, Galecki AT. Linear Mixed Models: A Practical Guide Using Statistical Software. Boca Raton, FL; Chapman Hall/CRC Press: 2007. [Google Scholar]
  • 26.Sapolsky RM. Glucocorticoids, stress, and their adverse neurological effects: relevance to aging. Experimental Gerontology. 1999;34(6):721–32. doi: 10.1016/s0531-5565(99)00047-9. [DOI] [PubMed] [Google Scholar]
  • 27.Chen P, Ganguli M, Mulsant BH, DeKosky ST. The temporal relationship between depressive symptoms and dementia: a community-based prospective study. Archives of General Psychiatry. 1999 Mar;56(3):261–6. doi: 10.1001/archpsyc.56.3.261. [DOI] [PubMed] [Google Scholar]
  • 28.Comijs HC, Jonker C, Beekman AT, Deeg DJ. The association between depressive symptoms and cognitive decline in community-dwelling elderly persons. Int J Geriatr Psychiatry. 2001 Apr;16(4):361–7. doi: 10.1002/gps.343. [DOI] [PubMed] [Google Scholar]
  • 29.Elias MF, Elias PK, Sullivan LM, Wolf PA, D’Agostino RB. Obesity, diabetes and cognitive deficit: The Framingham Heart Study. Neurobiol Aging. 2005 Oct 10; doi: 10.1016/j.neurobiolaging.2005.08.019. [DOI] [PubMed] [Google Scholar]
  • 30.Wolf PA, Beiser A, Elias MF, Au R, Vasan RS, Seshadri S. Relation of obesity to cognitive function: importance of central obesity and synergistic influence of concomitant hypertension. The Framingham Heart Study. Curr Alzheimer Res. 2007 Apr;4(2):111–6. doi: 10.2174/156720507780362263. [DOI] [PubMed] [Google Scholar]
  • 31.González HM, Haan MN, Hinton L. Acculturation and the prevalence of depression in older Mexican Americans: baseline results of the Sacramento Area Latino Study on Aging. Journal of the American Geriatrics Society. 2001 Jul;49(7):948–53. doi: 10.1046/j.1532-5415.2001.49186.x. [DOI] [PubMed] [Google Scholar]

RESOURCES